Neurocrine Biosciences
NBIX
$199.14
Share price
-1.49%
Change (1 day)
-15.25%
Change (1 year)
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.
Earnings for Neurocrine Biosciences (NBIX)
Earnings in 2024 (TTM): NZ$0.85 Billion
According to Neurocrine Biosciences 's latest financial reports the company's current earnings are NZ$2.35 Billion. , an increase over its 2023 earnings that were of NZ$0.54 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Neurocrine Biosciences from 1996 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | NZ$0.89 B | 64.57% |
| 2023 | NZ$0.54 B | 41.13% |
| 2022 | NZ$0.38 B | 73.74% |
| 2021 | NZ$0.22 B | -8.82% |
| 2020 | NZ$0.24 B | 77.78% |
| 2019 | NZ$0.13 B | 49.83% |
| 2018 | NZ$91.12 M | -142.57% |
| 2017 | -NZ$0.22 Billion | -14.73% |
| 2016 | -NZ$0.26 Billion | 53.15% |
| 2015 | -NZ$0.17 Billion | 46.25% |
| 2014 | -NZ$0.12 Billion | 29.66% |
| 2013 | -NZ$86.44 Million | -3530.8% |
| 2012 | NZ$2.51 M | -95.73% |
| 2011 | NZ$59.02 M | |
| 2009 | -NZ$82.98 Million | -45.38% |
| 2008 | -NZ$0.16 Billion | -58.87% |
| 2007 | -NZ$0.37 Billion | 87.3% |
| 2006 | -NZ$0.2 Billion | 351.97% |
| 2005 | -NZ$43.63 Million | -52.09% |
| 2004 | -NZ$91.07 Million | -10.98% |
| 2003 | -NZ$0.11 Billion | |
| 2001 | -NZ$76.36 Million | |
| 1999 | -NZ$34.44 Million | 108.32% |
| 1998 | -NZ$16.53 Million | |
| 1996 | NZ$5.04 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | NZ$33.44 M | -96.26% | 🇺🇸 USA |
 | NZ$2.70 B | 203.20% | 🇬🇧 UK |
 | -NZ$46.88 Million | -105.25% | 🇺🇸 USA |
 | NZ$22.06 B | 2,370.37% | 🇺🇸 USA |
 | NZ$6.46 B | 623.94% | 🇺🇸 USA |
 | NZ$19.33 B | 2,065.01% | 🇺🇸 USA |
 | -NZ$38.65 Million | -104.33% | 🇺🇸 USA |
 | -NZ$72.67 Million | -108.14% | 🇺🇸 USA |